Mechanisms of ceftriaxone prophylaxis against late bacteremic vascular graft infection caused byStaphylococcus aureus in a dog model View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1991-11

AUTHORS

Catherine Leport, Olivier Goëau-Brissonnière, Claude Lebrault, Jean Louis Vildé, Jean Claude Pechére

ABSTRACT

Possible mechanisms of the prophylactic effect of ceftriaxone against late bacteremic vascular graft infection in dogs were investigated. Dogs bearing an expanded polytetrafluoroethylene graft implanted as thoracoabdominal aortic bypass for one month were exposed to transient bacteremia produced by intravenous injection of 2.6±1.8 × 108 colony forming unitsStaphylococcus aureus 209P-R. To assess the effect of the antibiotic on bacteria already adherent onto the grafts, we compared the results from six untreated dogs used as controls and six dogs receiving ceftriaxone (0.5 g, intramuscularly) 90 minutes after the bacteremic challenge. The grafts were removed one week after the bacteremic challenge and cut into 10 to 15 fragments, each submitted to viable bacterial counts. The number of grafts and the number of fragments yielding bacterial growth were the same in the two groups. However, the median density of bacteria was lower (p< 0.01) in the dogs given ceftriaxone, 64 colony forming units/cm (range: 3–8,700), than in the control dogs, 585 colony forming units/cm (range: 12–64,000), suggesting that ceftriaxone had an effect on the postadherence phase of the development of infection. To assess the effect of ceftriaxone on the adherence phase we compared the results from seven untreated dogs and seven dogs receiving ceftriaxone (0.5 g intramuscularly) 90 minutes before the bacteremic challenge. The grafts were removed two hours after the bacteremic challenge. Though all the seven grafts were colonized in each group, the number of fragments yielding bacterial growth was lower (p<0.05) in the dogs given ceftriaxone (59/70) than in the control dogs (90/91). Several mechanisms may be responsible for successful antibiotic prophylaxis of graft infection, involving both early events and postadherence effects. More... »

PAGES

500-505

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf02015272

DOI

http://dx.doi.org/10.1007/bf02015272

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052748715

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1772756


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aorta, Abdominal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aorta, Thoracic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bacteremia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bacterial Adhesion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Vessel Prosthesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ceftriaxone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colony Count, Microbial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dogs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intramuscular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polytetrafluoroethylene", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prosthesis-Related Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Staphylococcal Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Staphylococcus aureus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Departments of Surgery and Anesthesiology, Ambroise Par\u00e9 Hospital and Ren\u00e9 Descartes University, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "Department of Infectious and Tropical Diseases and INSERM U13, Claude Bernard Hospital, Paris, France", 
            "Department of Microbiology, University of Geneva, Geneva, Switzerland", 
            "Departments of Surgery and Anesthesiology, Ambroise Par\u00e9 Hospital and Ren\u00e9 Descartes University, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leport", 
        "givenName": "Catherine", 
        "id": "sg:person.01213772510.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213772510.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Surgery and Anesthesiology, Ambroise Par\u00e9 Hospital and Ren\u00e9 Descartes University, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "Department of Infectious and Tropical Diseases and INSERM U13, Claude Bernard Hospital, Paris, France", 
            "Department of Microbiology, University of Geneva, Geneva, Switzerland", 
            "Departments of Surgery and Anesthesiology, Ambroise Par\u00e9 Hospital and Ren\u00e9 Descartes University, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Go\u00ebau-Brissonni\u00e8re", 
        "givenName": "Olivier", 
        "id": "sg:person.01041761557.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041761557.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Surgery and Anesthesiology, Ambroise Par\u00e9 Hospital and Ren\u00e9 Descartes University, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "Department of Infectious and Tropical Diseases and INSERM U13, Claude Bernard Hospital, Paris, France", 
            "Department of Microbiology, University of Geneva, Geneva, Switzerland", 
            "Departments of Surgery and Anesthesiology, Ambroise Par\u00e9 Hospital and Ren\u00e9 Descartes University, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lebrault", 
        "givenName": "Claude", 
        "id": "sg:person.01177146277.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177146277.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Surgery and Anesthesiology, Ambroise Par\u00e9 Hospital and Ren\u00e9 Descartes University, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "Department of Infectious and Tropical Diseases and INSERM U13, Claude Bernard Hospital, Paris, France", 
            "Department of Microbiology, University of Geneva, Geneva, Switzerland", 
            "Departments of Surgery and Anesthesiology, Ambroise Par\u00e9 Hospital and Ren\u00e9 Descartes University, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vild\u00e9", 
        "givenName": "Jean Louis", 
        "id": "sg:person.01341242120.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341242120.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Surgery and Anesthesiology, Ambroise Par\u00e9 Hospital and Ren\u00e9 Descartes University, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "Department of Infectious and Tropical Diseases and INSERM U13, Claude Bernard Hospital, Paris, France", 
            "Department of Microbiology, University of Geneva, Geneva, Switzerland", 
            "Departments of Surgery and Anesthesiology, Ambroise Par\u00e9 Hospital and Ren\u00e9 Descartes University, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pech\u00e9re", 
        "givenName": "Jean Claude", 
        "id": "sg:person.016245105657.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016245105657.70"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1991-11", 
    "datePublishedReg": "1991-11-01", 
    "description": "Possible mechanisms of the prophylactic effect of ceftriaxone against late bacteremic vascular graft infection in dogs were investigated. Dogs bearing an expanded polytetrafluoroethylene graft implanted as thoracoabdominal aortic bypass for one month were exposed to transient bacteremia produced by intravenous injection of 2.6\u00b11.8 \u00d7 108 colony forming unitsStaphylococcus aureus 209P-R. To assess the effect of the antibiotic on bacteria already adherent onto the grafts, we compared the results from six untreated dogs used as controls and six dogs receiving ceftriaxone (0.5 g, intramuscularly) 90 minutes after the bacteremic challenge. The grafts were removed one week after the bacteremic challenge and cut into 10 to 15 fragments, each submitted to viable bacterial counts. The number of grafts and the number of fragments yielding bacterial growth were the same in the two groups. However, the median density of bacteria was lower (p< 0.01) in the dogs given ceftriaxone, 64 colony forming units/cm (range: 3\u20138,700), than in the control dogs, 585 colony forming units/cm (range: 12\u201364,000), suggesting that ceftriaxone had an effect on the postadherence phase of the development of infection. To assess the effect of ceftriaxone on the adherence phase we compared the results from seven untreated dogs and seven dogs receiving ceftriaxone (0.5 g intramuscularly) 90 minutes before the bacteremic challenge. The grafts were removed two hours after the bacteremic challenge. Though all the seven grafts were colonized in each group, the number of fragments yielding bacterial growth was lower (p<0.05) in the dogs given ceftriaxone (59/70) than in the control dogs (90/91). Several mechanisms may be responsible for successful antibiotic prophylaxis of graft infection, involving both early events and postadherence effects.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf02015272", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1097002", 
        "issn": [
          "0890-5096", 
          "1615-5947"
        ], 
        "name": "Annals of Vascular Surgery", 
        "publisher": "Elsevier", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "vascular graft infection", 
      "bacteremic challenge", 
      "graft infection", 
      "untreated dogs", 
      "control dogs", 
      "thoracoabdominal aortic bypass", 
      "effects of ceftriaxone", 
      "development of infection", 
      "number of grafts", 
      "aortic bypass", 
      "ceftriaxone prophylaxis", 
      "antibiotic prophylaxis", 
      "transient bacteremia", 
      "prophylactic effect", 
      "polytetrafluoroethylene grafts", 
      "units/", 
      "intravenous injection", 
      "ceftriaxone", 
      "dog model", 
      "graft", 
      "infection", 
      "byStaphylococcus aureus", 
      "dogs", 
      "adherence phase", 
      "prophylaxis", 
      "viable bacterial counts", 
      "bacterial growth", 
      "early events", 
      "bacterial counts", 
      "possible mechanism", 
      "minutes", 
      "aureus 209P", 
      "bacteremia", 
      "median density", 
      "group", 
      "bypass", 
      "weeks", 
      "months", 
      "effect", 
      "injection", 
      "aureus", 
      "count", 
      "mechanism", 
      "hours", 
      "bacteria", 
      "number", 
      "control", 
      "fragments", 
      "challenges", 
      "colonies", 
      "number of fragments", 
      "events", 
      "results", 
      "growth", 
      "development", 
      "phase", 
      "model", 
      "density"
    ], 
    "name": "Mechanisms of ceftriaxone prophylaxis against late bacteremic vascular graft infection caused byStaphylococcus aureus in a dog model", 
    "pagination": "500-505", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052748715"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf02015272"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1772756"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf02015272", 
      "https://app.dimensions.ai/details/publication/pub.1052748715"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_234.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf02015272"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf02015272'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf02015272'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf02015272'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf02015272'


 

This table displays all metadata directly associated to this object as RDF triples.

210 TRIPLES      21 PREDICATES      100 URIs      92 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf02015272 schema:about N04f0f34992d7493d800bfeebaf1c062c
2 N0805b780a0314cb5aa8bc4e53497417f
3 N14c77d6af67b456db047215a27cc6fa3
4 N18ea247694324e4499787e8f2766d238
5 N2f1189e4c0894177a06480463af325f9
6 N30f9b7061e77402a858eb05311426b25
7 N6577efd0caf542de85c8f7967902611f
8 N67e54c72012c4fa1baa88d31a3e83ed4
9 N78d89fc52eb84142bc3c9037ecab4b75
10 N90e8ca5a2a6f46db88ce293ad83870b8
11 Nb429c60f759744b39903514e5c34dae5
12 Nc1ddb7cc83824cbc9c6af85783409a97
13 Nd1f69b24914b4cd787c9ff0799ebafba
14 Ne2d755c4deaf4a8d8769b9f9c58b4f45
15 Nf14a3b133eb74c39a5dbc7b08c245c63
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author N6d37255e11bb4aab8fb814a8764efc11
19 schema:datePublished 1991-11
20 schema:datePublishedReg 1991-11-01
21 schema:description Possible mechanisms of the prophylactic effect of ceftriaxone against late bacteremic vascular graft infection in dogs were investigated. Dogs bearing an expanded polytetrafluoroethylene graft implanted as thoracoabdominal aortic bypass for one month were exposed to transient bacteremia produced by intravenous injection of 2.6±1.8 × 108 colony forming unitsStaphylococcus aureus 209P-R. To assess the effect of the antibiotic on bacteria already adherent onto the grafts, we compared the results from six untreated dogs used as controls and six dogs receiving ceftriaxone (0.5 g, intramuscularly) 90 minutes after the bacteremic challenge. The grafts were removed one week after the bacteremic challenge and cut into 10 to 15 fragments, each submitted to viable bacterial counts. The number of grafts and the number of fragments yielding bacterial growth were the same in the two groups. However, the median density of bacteria was lower (p< 0.01) in the dogs given ceftriaxone, 64 colony forming units/cm (range: 3–8,700), than in the control dogs, 585 colony forming units/cm (range: 12–64,000), suggesting that ceftriaxone had an effect on the postadherence phase of the development of infection. To assess the effect of ceftriaxone on the adherence phase we compared the results from seven untreated dogs and seven dogs receiving ceftriaxone (0.5 g intramuscularly) 90 minutes before the bacteremic challenge. The grafts were removed two hours after the bacteremic challenge. Though all the seven grafts were colonized in each group, the number of fragments yielding bacterial growth was lower (p<0.05) in the dogs given ceftriaxone (59/70) than in the control dogs (90/91). Several mechanisms may be responsible for successful antibiotic prophylaxis of graft infection, involving both early events and postadherence effects.
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N432bdd5987d54b92b7fa212cb5f3bb52
26 Nb9b31a794c4a4f6b959ad039e9acb4ad
27 sg:journal.1097002
28 schema:keywords adherence phase
29 antibiotic prophylaxis
30 aortic bypass
31 aureus
32 aureus 209P
33 bacteremia
34 bacteremic challenge
35 bacteria
36 bacterial counts
37 bacterial growth
38 byStaphylococcus aureus
39 bypass
40 ceftriaxone
41 ceftriaxone prophylaxis
42 challenges
43 colonies
44 control
45 control dogs
46 count
47 density
48 development
49 development of infection
50 dog model
51 dogs
52 early events
53 effect
54 effects of ceftriaxone
55 events
56 fragments
57 graft
58 graft infection
59 group
60 growth
61 hours
62 infection
63 injection
64 intravenous injection
65 mechanism
66 median density
67 minutes
68 model
69 months
70 number
71 number of fragments
72 number of grafts
73 phase
74 polytetrafluoroethylene grafts
75 possible mechanism
76 prophylactic effect
77 prophylaxis
78 results
79 thoracoabdominal aortic bypass
80 transient bacteremia
81 units/
82 untreated dogs
83 vascular graft infection
84 viable bacterial counts
85 weeks
86 schema:name Mechanisms of ceftriaxone prophylaxis against late bacteremic vascular graft infection caused byStaphylococcus aureus in a dog model
87 schema:pagination 500-505
88 schema:productId N1dd6cf91ec2548e3acc845a299209df3
89 N41710bc420734be194a871428c3ad16a
90 Nf93e8b449f644e429b147be6ce5da02a
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052748715
92 https://doi.org/10.1007/bf02015272
93 schema:sdDatePublished 2022-05-20T07:19
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher Naa72631606354ae2ba9b3a608e5bc721
96 schema:url https://doi.org/10.1007/bf02015272
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N04f0f34992d7493d800bfeebaf1c062c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Bacteremia
102 rdf:type schema:DefinedTerm
103 N0805b780a0314cb5aa8bc4e53497417f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Staphylococcus aureus
105 rdf:type schema:DefinedTerm
106 N14c77d6af67b456db047215a27cc6fa3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Colony Count, Microbial
108 rdf:type schema:DefinedTerm
109 N18ea247694324e4499787e8f2766d238 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Dogs
111 rdf:type schema:DefinedTerm
112 N1dd6cf91ec2548e3acc845a299209df3 schema:name dimensions_id
113 schema:value pub.1052748715
114 rdf:type schema:PropertyValue
115 N2f1189e4c0894177a06480463af325f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Time Factors
117 rdf:type schema:DefinedTerm
118 N30f9b7061e77402a858eb05311426b25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Ceftriaxone
120 rdf:type schema:DefinedTerm
121 N40b239244b114630a2266f6f73bd075a rdf:first sg:person.016245105657.70
122 rdf:rest rdf:nil
123 N410ee475281549cc9f770b45bb7a2916 rdf:first sg:person.01341242120.65
124 rdf:rest N40b239244b114630a2266f6f73bd075a
125 N41710bc420734be194a871428c3ad16a schema:name doi
126 schema:value 10.1007/bf02015272
127 rdf:type schema:PropertyValue
128 N432bdd5987d54b92b7fa212cb5f3bb52 schema:volumeNumber 5
129 rdf:type schema:PublicationVolume
130 N6577efd0caf542de85c8f7967902611f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Animals
132 rdf:type schema:DefinedTerm
133 N67e54c72012c4fa1baa88d31a3e83ed4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Aorta, Thoracic
135 rdf:type schema:DefinedTerm
136 N6d37255e11bb4aab8fb814a8764efc11 rdf:first sg:person.01213772510.09
137 rdf:rest N6d5c9b275b434b0781049b06612cf017
138 N6d5c9b275b434b0781049b06612cf017 rdf:first sg:person.01041761557.50
139 rdf:rest Nfc85ed3b92ec4a6794040a459068df70
140 N78d89fc52eb84142bc3c9037ecab4b75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Prosthesis-Related Infections
142 rdf:type schema:DefinedTerm
143 N90e8ca5a2a6f46db88ce293ad83870b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Blood Vessel Prosthesis
145 rdf:type schema:DefinedTerm
146 Naa72631606354ae2ba9b3a608e5bc721 schema:name Springer Nature - SN SciGraph project
147 rdf:type schema:Organization
148 Nb429c60f759744b39903514e5c34dae5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Bacterial Adhesion
150 rdf:type schema:DefinedTerm
151 Nb9b31a794c4a4f6b959ad039e9acb4ad schema:issueNumber 6
152 rdf:type schema:PublicationIssue
153 Nc1ddb7cc83824cbc9c6af85783409a97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Aorta, Abdominal
155 rdf:type schema:DefinedTerm
156 Nd1f69b24914b4cd787c9ff0799ebafba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Polytetrafluoroethylene
158 rdf:type schema:DefinedTerm
159 Ne2d755c4deaf4a8d8769b9f9c58b4f45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Staphylococcal Infections
161 rdf:type schema:DefinedTerm
162 Nf14a3b133eb74c39a5dbc7b08c245c63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Injections, Intramuscular
164 rdf:type schema:DefinedTerm
165 Nf93e8b449f644e429b147be6ce5da02a schema:name pubmed_id
166 schema:value 1772756
167 rdf:type schema:PropertyValue
168 Nfc85ed3b92ec4a6794040a459068df70 rdf:first sg:person.01177146277.53
169 rdf:rest N410ee475281549cc9f770b45bb7a2916
170 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
171 schema:name Medical and Health Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
174 schema:name Clinical Sciences
175 rdf:type schema:DefinedTerm
176 sg:journal.1097002 schema:issn 0890-5096
177 1615-5947
178 schema:name Annals of Vascular Surgery
179 schema:publisher Elsevier
180 rdf:type schema:Periodical
181 sg:person.01041761557.50 schema:affiliation grid-institutes:grid.508487.6
182 schema:familyName Goëau-Brissonnière
183 schema:givenName Olivier
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041761557.50
185 rdf:type schema:Person
186 sg:person.01177146277.53 schema:affiliation grid-institutes:grid.508487.6
187 schema:familyName Lebrault
188 schema:givenName Claude
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177146277.53
190 rdf:type schema:Person
191 sg:person.01213772510.09 schema:affiliation grid-institutes:grid.508487.6
192 schema:familyName Leport
193 schema:givenName Catherine
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213772510.09
195 rdf:type schema:Person
196 sg:person.01341242120.65 schema:affiliation grid-institutes:grid.508487.6
197 schema:familyName Vildé
198 schema:givenName Jean Louis
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341242120.65
200 rdf:type schema:Person
201 sg:person.016245105657.70 schema:affiliation grid-institutes:grid.508487.6
202 schema:familyName Pechére
203 schema:givenName Jean Claude
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016245105657.70
205 rdf:type schema:Person
206 grid-institutes:grid.508487.6 schema:alternateName Departments of Surgery and Anesthesiology, Ambroise Paré Hospital and René Descartes University, Paris, France
207 schema:name Department of Infectious and Tropical Diseases and INSERM U13, Claude Bernard Hospital, Paris, France
208 Department of Microbiology, University of Geneva, Geneva, Switzerland
209 Departments of Surgery and Anesthesiology, Ambroise Paré Hospital and René Descartes University, Paris, France
210 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...